Form 4 for SKIN SkinHealth Systems Inc.
Accepted 2023-03-06 00:00:00 ET · period of report 2023-03-01 · accession 0001818093-23-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-06 | 2023-03-01 | SKIN | Woo Liyuan | CFO | A - Grant | — | +18.7K | 473.6K | +4% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-03-01 | A | A | 18,746 | — | 473,557 | D | — | — | (F1) Represents a grant of restricted stock units that vests in one year on the anniversary of the grant date of March 1, 2023, subject to continued service through the vesting date and certain acceleration rights. (F2) These shares include 1,843 shares of Class A Common Stock acquired by the reporting person under the Company's 2021 Employee Stock Purchase Plan |